Search research articles
Contact Us
Filters
Showing results (31-40 of 116) with videos related to
Page
of 12
Sort By:
Journal for Immunotherapy of Cancer
|
December 30, 2016
A phase IB study of ipilimumab with peginterferon alfa-2b in patients with unresectable melanoma
Andrew S Brohl, Nikhil I Khushalani, Zeynep Eroglu, et al.
Geriatrics & Gerontology International
|
July 10, 2026
The Relationship Between Voluntary Rapid Blinking Rate and Future Development of Neurodegenerative Disease
Remzi Bahsi, Zeynep Eroglu Soysal, Volkan Atmis, et al.
Cancers
|
February 27, 2026
Survival Assessment by Central Review vs. Local Investigator in Metastatic Melanoma: A Systematic Review and Meta-Analysis
Islam Eljilany, Eissa Jafari, Abdullah Alhumaid, et al.
Seminars in Cancer Biology
|
November 6, 2019
Translational pathology, genomics and the development of systemic therapies for acral melanoma
Yian Ann Chen, Jamie K Teer, Zeynep Eroglu, et al.
Cancers
|
June 28, 2023
Cetuximab for Immunotherapy-Refractory/Ineligible Cutaneous Squamous Cell Carcinoma
Julian A Marin-Acevedo, Bethany M Withycombe, Youngchul Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 24, 2025
Combined Targeting of PD-1 and TIM-3 in Patients with Locally Advanced or Metastatic Melanoma: AMBER Cohorts 1c, 1e, and 2A
Diwakar Davar, Zeynep Eroglu, Casilda Llácer Pérez, et al.
Pigment Cell & Melanoma Research
|
April 19, 2016
Comparative analysis of the GNAQ, GNA11, SF3B1, and EIF1AX driver mutations in melanoma and across the cancer spectrum
Douglas B Johnson, Jason Roszik, Alexander N Shoushtari, et al.
Dermatology and Therapy
|
December 19, 2025
Real-World Treatment Patterns of Patients with Basal Cell Carcinoma Using Sonidegib and Vismodegib: Discontinuation Rates and Clinical Conditions During Treatment
Mark G Lebwohl, Darrell S Rigel, Zeynep Eroglu, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
March 19, 2019
Clinical Correlates of Response to Anti-PD-1-based Therapy in Patients With Metastatic Melanoma
Elizabeth J Davis, Matthew C Perez, Noura Ayoubi, et al.
Journal for Immunotherapy of Cancer
|
October 26, 2016
Safety and efficacy of anti-PD-1 in patients with baseline cardiac, renal, or hepatic dysfunction
Bridgette A Kanz, Megan H Pollack, Romany Johnpulle, et al.
Page
of 12
Search research articles
Search
Showing results (31-40 of 116) with videos related to
Sort By:
Page
of 12
Journal for Immunotherapy of Cancer
|
December 30, 2016
A phase IB study of ipilimumab with peginterferon alfa-2b in patients with unresectable melanoma
Andrew S Brohl, Nikhil I Khushalani, Zeynep Eroglu, et al.
Geriatrics & Gerontology International
|
July 10, 2026
The Relationship Between Voluntary Rapid Blinking Rate and Future Development of Neurodegenerative Disease
Remzi Bahsi, Zeynep Eroglu Soysal, Volkan Atmis, et al.
Cancers
|
February 27, 2026
Survival Assessment by Central Review vs. Local Investigator in Metastatic Melanoma: A Systematic Review and Meta-Analysis
Islam Eljilany, Eissa Jafari, Abdullah Alhumaid, et al.
Seminars in Cancer Biology
|
November 6, 2019
Translational pathology, genomics and the development of systemic therapies for acral melanoma
Yian Ann Chen, Jamie K Teer, Zeynep Eroglu, et al.
Cancers
|
June 28, 2023
Cetuximab for Immunotherapy-Refractory/Ineligible Cutaneous Squamous Cell Carcinoma
Julian A Marin-Acevedo, Bethany M Withycombe, Youngchul Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 24, 2025
Combined Targeting of PD-1 and TIM-3 in Patients with Locally Advanced or Metastatic Melanoma: AMBER Cohorts 1c, 1e, and 2A
Diwakar Davar, Zeynep Eroglu, Casilda Llácer Pérez, et al.
Pigment Cell & Melanoma Research
|
April 19, 2016
Comparative analysis of the GNAQ, GNA11, SF3B1, and EIF1AX driver mutations in melanoma and across the cancer spectrum
Douglas B Johnson, Jason Roszik, Alexander N Shoushtari, et al.
Dermatology and Therapy
|
December 19, 2025
Real-World Treatment Patterns of Patients with Basal Cell Carcinoma Using Sonidegib and Vismodegib: Discontinuation Rates and Clinical Conditions During Treatment
Mark G Lebwohl, Darrell S Rigel, Zeynep Eroglu, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
March 19, 2019
Clinical Correlates of Response to Anti-PD-1-based Therapy in Patients With Metastatic Melanoma
Elizabeth J Davis, Matthew C Perez, Noura Ayoubi, et al.
Journal for Immunotherapy of Cancer
|
October 26, 2016
Safety and efficacy of anti-PD-1 in patients with baseline cardiac, renal, or hepatic dysfunction
Bridgette A Kanz, Megan H Pollack, Romany Johnpulle, et al.
Page
of 12